Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs

Fig. 2

Least squares mean (LSM) changes from baseline: Patient Global Assessment of Disease Activity (PtGA) (a), Patient Global Assessment of Pain (Pain) (b), and Health Assessment Questionnaire-Disability Index (HAQ-DI) (c), over time; *p <0.05; **p <0.01; ***p <0.0001 vs placebo. MCID minimum clinically important difference, BID twice daily, SE standard error

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us